| 000 | 01230 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513202058.0 | ||
| 264 | 0 | _c20000210 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 024 | 7 |
_a10.1016/s0002-9343(99)00390-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDieterich, D T | |
| 245 | 0 | 0 |
_aHepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cDec 1999 |
||
| 300 |
_a79S-84S p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 773 | 0 |
_tThe American journal of medicine _gvol. 107 _gno. 6B _gp. 79S-84S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9343(99)00390-3 _zAvailable from publisher's website |
| 999 |
_c10608496 _d10608496 |
||